Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25+0.04 (+3.31%)
Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%
Nkarta EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Nkarta
Nkarta has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?